SLD Saluda Medical, Inc.
—Mkt Cap: —P/E: —1d ago
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platfor…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value52.95M USD
Revenue (TTM)62.32M USD
Gross Profit30.47M USD
Net Income (TTM)-165.59M USD
Revenue/Share0.56 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU0000432114
Valuation
P/E (Trailing)—
P/E (Forward)-0.94
PEG—
EV/EBITDA-0.54
EV/Revenue0.85
P/S1.07
P/B1.23
EPS (TTM)-13.29
EPS (Forward)-0.40
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin48.89%
Oper. Margin-156.43%
EBITDA Margin-158.23%
Profit Margin-165.87%
ROE—
ROA-56.97%
Growth
Revenue Growth38.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-80.15M USD
CapEx (TTM)—
FCF Margin-66.94%
FCF Yield—
Net Debt-11.49M USD
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity182.84
Current Ratio5.43
Quick Ratio4.14
Book Value/Sh0.31 AUD
Cash/Share0.46 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.006 AUD
Target Range1.659 AUD – 2.264 AUD
# Analysts3
Ownership
Shares Out.254.76M
Float106.91M
Insiders15.14%
Institutions30.62%
Technical
SMA 500.4736 AUD
SMA 2000.6701 AUD
Beta—
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)196.56K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—